SMTL ID : 1o48.1

CRYSTAL STRUCTURE OF SH2 IN COMPLEX WITH RU85053.

Coordinates

PDB Format Compare

Method

X-RAY DIFFRACTION 1.55 Å

Oligo State

monomer

Ligands

1 x 853: 5-[2-ACETYLAMINO-2-(1-BIPHENYL-4-YLMETHYL-2-OXO-AZEPAN-3-YLCARBAMOYL)-ETHYL]-2-CARBOXYMETHYL-BENZOIC ACID(Non-covalent)

853.1: 16 residues within 4Å: Chain A: R.14, R.34, S.36, E.37, T.38, C.44, K.59, H.60, Y.61, K.62, I.73, T.74, Y.89, D.94, G.95, L.96 20 PLIP interactions: 20 interactions with chain A Hydrophobic interactions: A:K.59, A:H.60, A:Y.61, A:Y.61, A:K.62, A:K.62, A:T.74, A:Y.89, A:D.94, A:L.96 Hydrogen bonds: A:R.14, A:R.14, A:E.37, A:H.60 Water bridges: A:S.36, A:T.39, A:H.60 Salt bridges: A:R.14, A:R.34 pi-Cation interactions: A:R.14

Links

RCSB   PDBe   PDBe-KB   PDBj   PDBsum   CATH   PLIP

Citation

Lange, G. et al., Requirements for specific binding of low affinity inhibitor fragments to the SH2 domain of (pp60)Src are identical to those for high affinity binding of full length inhibitors. J.Med.Chem. (2003)

Release Date

2004-02-17

Peptides

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC: A

SMTL:PDB

SMTL Chain Id:
PDB Chain Id:

A
A

PROTO-ONCOGENE TYROSINE-PROTEIN KINASE SRC

Related Entries With Identical Sequence